Search results (86)
« Back to PublicationsLipoprotein(a) and Vascular Redox State in Patients With Advanced Coronary Atherosclerosis.
Journal article
Polkinghorne MD. et al, (2026), Arterioscler Thromb Vasc Biol, 46, 232 - 247
Expression of Concern for Elevated circulating amyloid concentrations in obesity and diabetes promote vascular dysfunction.
Journal article
Meakin PJ. et al, (2025), J Clin Invest, 135
Network meta-analysis of cardioplegic methods, in elective isolated coronary artery bypass grafting.
Journal article
Kalogerakos PD. et al, (2025), Perfusion
Emerging Roles for Sphingolipids in Cardiometabolic Disease: A Rational Therapeutic Target?
Journal article
Foran D. et al, (2024), Nutrients, 16
Emerging Roles for Sphingolipids in Cardiometabolic Disease: A Rational Therapeutic Target?
Preprint
Foran D. et al, (2024)
Editorial commentary: Revisiting time-restricted-eating interventions for cardiometabolic risk reduction: Do they have a clinically relevant role?
Journal article
Akoumianakis I., (2024), Trends Cardiovasc Med, 34, 402 - 403
High-Flow Nasal Oxygen for Severe COVID-19 Pneumonia in Greek Patients: A Prospective Observational Study.
Journal article
Ioannou P. et al, (2023), Kurume Med J, 69, 53 - 63
GLP-1 analogs and regional adiposity: A systematic review and meta-analysis.
Journal article
Akoumianakis I. et al, (2023), Obes Rev, 24
Role of Human Epicardial Adipose Tissue-Derived miR-92a-3p in Myocardial Redox State.
Journal article
Carena MC. et al, (2023), J Am Coll Cardiol, 82, 317 - 332
PHACTR1 modulates vascular compliance but not endothelial function: a translational study.
Journal article
Wood A. et al, (2023), Cardiovasc Res, 119, 599 - 610
Human epicardial adipose tissue-secreted miR-92a-3p regulates myocardial redox state via paracrine signalling: implications for cardiovascular clinical outcomes
Journal article
Badi I. et al, (2023), EUROPEAN HEART JOURNAL, 44
GENETIC VARIABILITY OF LIPOPROTEIN(A) CONTROLS VASCULAR INFLAMMATION/REDOX SIGNALLING AND PREDICTS ADVERSE CARDIOVASCULAR OUTCOMES IN CORONARY ARTERY DISEASE
Journal article
Polkinghorne M. et al, (2023), ATHEROSCLEROSIS, 379
Genetic variability of lipoprotein(a) controls vascular inflammation/redox signalling and predicts adverse cardiovascular outcomes in coronary artery disease N.
Journal article
Polkinghorne MD. et al, (2023), EUROPEAN HEART JOURNAL, 44
dipose Tissue Derived Ceramides Regulate Myocardial Redox State and Predict Cardiovascular Outcomes in Patients With Ischaemic Heart Disease
Conference paper
Polkinghorne MD. et al, (2023), CIRCULATION RESEARCH, 133, E65 - E65
THE ROLE OF CTA RADIOTRANSCRIPTOMIC PHENOTYPING IN UNDERSTANDING THE VASCULAR EFFECTS OF LP(A) IN ADVANCED ATHEROSCLEROSIS
Conference paper
Xie C. et al, (2023), HEART, 109, A270 - A271